Internal Server Error

List of Regeneron Pharmaceuticals's Acquisitions

lockFilter this list
Regeneron Pharmaceuticals has consistently expanded its capabilities through acquisitions. Peak acquisition years include 2025, 2023, and 2022, each with 1 acquisition. Its acquisition activity has covered 2 countries, United States and United Kingdom. The company has made acquisitions across 5 sectors, including Immunotherapy (2 acquisitions), Oncology (1 acquisition), and Ophthalmology (1 acquisition). Over the last five years (2020–2025), the average annual acquisitions totaled 0.6, with 0 acquisitions so far this current calendar year. The most recent acquisition, completed in January 2025, was Oxular, an Oxford-based developer of drug delivery platforms and ophthalmology therapeutics, founded in 2014.

Here's the year on year acquisition history of Regeneron Pharmaceuticals:

Year on year acquisition history of Regeneron Pharmaceuticals202520232022Acquisitions Round Date (Yearly)012
  • Number of Total Acquisitions
Year
# Acquisitions
2025
1
2023
1
2022
1

Recent acquisitions by Regeneron Pharmaceuticals

Regeneron Pharmaceuticals's most recent acquisition - Oxular is a Developer of drug delivery platform and therapeutics for ophthalmology, founded in 2014 and located in Oxford. Regeneron Pharmaceuticals acquired it in January 2025 for a price of $*****.

Here is the list of all acquisitions by Regeneron Pharmaceuticals sorted by the latest acquisition date:

Acquired on
Acquired Company
Acquisition Price
Facilitators
Stake Acquired
Acquisition Multiple
Jan 02, 2025
fk{s
gawe
58
345
Aug 10, 2023
ytnr
nhjh
24
381
Apr 19, 2022
alsa
pf{p
46
722

News related to Regeneron Pharmaceuticals's acquisitions

lockFilter this list

Media has covered Regeneron Pharmaceuticals for a total of 150 events in the last 1 year, 13 of them have been about acquisition activity.

View More Regeneron Pharmaceuticals Recent News

FAQs about Acquisitions by Regeneron Pharmaceuticals

Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford